Open Access

Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway

Retraction in: /10.3892/mmr.2024.13192

  • Authors:
    • Huiying Qiao
    • Haiyan Ren
    • He Du
    • Minfang Zhang
    • Xiaofang Xiong
    • Rong Lv
  • View Affiliations

  • Published online on: January 2, 2018     https://doi.org/10.3892/mmr.2018.8371
  • Pages: 3722-3734
  • Copyright: © Qiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Liraglutide is glucagon‑like peptide‑1 receptor agonist used for treating patients with type 2 diabetes mellitus. The present study aimed to investigate the role and mechanism of liraglutide in repairing the infarcted heart following myocardial infarction. The results of the present study demonstrated that amplification of the dose of liraglutide for ~28 days was able to reduce cardiac fibrosis, inflammatory responses and myocardial death in the post‑infarcted heart. In vitro, liraglutide protected cardiomyocyte mitochondria against the chronic hypoxic damage, inhibiting the mitochondrial apoptosis pathways. Mechanistically, liraglutide elevated the expression of NAD‑dependent protein deacetylase sirtuin‑1 (SIRT1), which increased the expression of Parkin, leading to mitophagy activation. Protective mitophagy reversed cellular adenosine 5'‑triphosphate production, reduced cellular oxidative stress and balanced the redox response, sustaining mitochondrial homeostasis. Notably, following blockade of glucagon‑like peptide 1 receptor or knockdown of Parkin, the beneficial effects of liraglutide on mitochondria disappeared. In conclusion, the results of the present study illustrated the protective role of liraglutide in repairing the infarcted heart via regulation of the SIRT1/Parkin/mitophagy pathway.
View Figures
View References

Related Articles

Journal Cover

March-2018
Volume 17 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qiao H, Ren H, Du H, Zhang M, Xiong X and Lv R: Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway Retraction in /10.3892/mmr.2024.13192. Mol Med Rep 17: 3722-3734, 2018.
APA
Qiao, H., Ren, H., Du, H., Zhang, M., Xiong, X., & Lv, R. (2018). Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway Retraction in /10.3892/mmr.2024.13192. Molecular Medicine Reports, 17, 3722-3734. https://doi.org/10.3892/mmr.2018.8371
MLA
Qiao, H., Ren, H., Du, H., Zhang, M., Xiong, X., Lv, R."Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway Retraction in /10.3892/mmr.2024.13192". Molecular Medicine Reports 17.3 (2018): 3722-3734.
Chicago
Qiao, H., Ren, H., Du, H., Zhang, M., Xiong, X., Lv, R."Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway Retraction in /10.3892/mmr.2024.13192". Molecular Medicine Reports 17, no. 3 (2018): 3722-3734. https://doi.org/10.3892/mmr.2018.8371